INS and Alzheimer disease: Researchers have postulated that diabetes could be a novel mechanism of neurodegeneration wherein the classical AD pathophysiology can be explained from the perspective of unregulated insulin/IGF (insulin‐like growth factor) signaling and improper glucose metabolism.